Selected top branded biologic drugs in the United States that will go generic between 2016 and 2028, by revenue (in billion U.S. dollars)*

Top branded biologic drugs in the U.S. that will go generic by 2028 This statistic shows a list of selected top branded biologic drugs in the United States that will go generic by 2028 as a result of expired patents, listed by revenue. One of these top branded drugs is Humira, which generates around 8.5 billion U.S. dollars worth of revenue in the U.S. pharmaceutical market annually and will go generic in 2016.
Show more
Loading statistic...
Drug name and date of patent expiryRevenue in billion U.S. dollars
Humira (2016)8.5
Rituxan (2016)3.6
Remicade (2018)4.7
Enbrel (2028)6.1
Drug name and date of patent expiryRevenue in billion U.S. dollars
Humira (2016)8.5
Rituxan (2016)3.6
Remicade (2018)4.7
Enbrel (2028)6.1
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic shows a list of selected top branded biologic drugs in the United States that will go generic by 2028 as a result of expired patents, listed by revenue. One of these top branded drugs is Humira, which generates around 8.5 billion U.S. dollars worth of revenue in the U.S. pharmaceutical market annually and will go generic in 2016.
Show more
Release date
2016
Region
United States
Survey time period
2016
Supplementary notes
* For all of these drugs, the existing patent will expire by 2028, which allows generic versions to then be made thereafter. The statistic is based on U.S. revenue only.
Revenue figures are the moving annual total (MAT) for June 2015.

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:

Related Studies: Available to Download in PDF or PPTX Format

U.S. pharmaceutical industry

All Information
in one Presentation

U.S. pharmaceutical industry

Everything On "U.S. pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "U.S. pharmaceutical industry"

  • Contribution to global pharma
The most important statistics
  • Overview
  • Companies
  • Research and development
The most important statistics
  • Generics
The most important statistics
  • Outlook
  • The consumer's view
The most important statistics
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

4 News

We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.